CAS: 84633-34-1 - Shatavarin IV
Fórmula:C45H74O17
InChI:InChI=1S/C45H74O17/c1-19-8-13-45(55-18-19)20(2)30-27(62-45)15-26-24-7-6-22-14-23(9-11-43(22,4)25(24)10-12-44(26,30)5)57-42-39(61-41-36(53)34(51)32(49)28(16-46)58-41)37(54)38(29(17-47)59-42)60-40-35(52)33(50)31(48)21(3)56-40/h19-42,46-54H,6-18H2,1-5H3/t19-,20-,21-,22+,23-,24+,25-,26-,27-,28+,29+,30-,31-,32+,33+,34-,35+,36+,37-,38+,39+,40-,41-,42+,43-,44-,45+/m0/s1
Chave InChI:InChIKey=BCUDKRWNGQAFLF-PJFZGHSASA-N
SMILES:OCC1OC(OC2C(O)C(OC3OC(C)C(O)C(O)C3O)C(OC2OC4CCC5(C)C(CCC6C5CCC7(C)C6CC8OC9(OCC(C)CC9)C(C)C87)C4)CO)C(O)C(O)C1O
- Sinónimos:
- Asparanin B
- (3β,5β,25S)-Spirostan-3-yl O-6-deoxy-α-L-mannopyranosyl-(1→4)-O-[β-D-glucopyranosyl-(1→2)]-β-D-glucopyranoside
- Curillin H
- β-D-Glucopyranoside, (3β,5β,25S)-spirostan-3-yl O-6-deoxy-α-L-mannopyranosyl-(1→4)-O-[β-D-glucopyranosyl-(1→2)]-
- Shatavarin IV
Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
---|---|---|---|---|
Asparanin B REF: 7W-GL3978CAS: 84633-34-1 | ≥ 90.0% | A consultar | Ter 07 Jan 25 | |
Shatavarin IV REF: TM-TN5004CAS: 84633-34-1 | 98% | A consultar | Ter 07 Jan 25 | |
Asparanin B REF: BP-BP2167CAS: 84633-34-1 | 95%~99% | 209,00 €~1.434,00 € | Qua 08 Jan 25 | |
Shatavarin iv REF: 5G-80536CAS: 84633-34-1 | ≥ 90.0 % (HPLC) | 405,00 €~29.306,00 € | Ter 14 Jan 25 | |
Asparanin B REF: 3D-JDA63334CAS: 84633-34-1 | 75%Min | 647,00 €~4.637,00 € | Ter 04 Mar 25 |
Asparanin B
Ref: 7W-GL3978
Tamanho indefinido | A consultar |
Shatavarin IV
Ref: TM-TN5004
10mg | 925,00 € | ||
1mL*10mM (DMSO) | 944,00 € |
Ref: BP-BP2167
5mg | 209,00 € | ||
10mg | 326,00 € | ||
20mg | 491,00 € | ||
100mg | 1.434,00 € |
Shatavarin iv
Ref: 5G-80536
10mg | 405,00 € | ||
50mg | 1.759,00 € | ||
250mg | 8.304,00 € | ||
500mg | 15.630,00 € | ||
1000mg | 29.306,00 € |
Asparanin B
Ref: 3D-JDA63334
1mg | 647,00 € | ||
2mg | 986,00 € | ||
5mg | 1.449,00 € | ||
10mg | 2.319,00 € | ||
25mg | 4.637,00 € |